Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Combining Real World and Clinical Trials for Totality of Evidence

被引：3
|
作者：
Khor, Yet H. [1 ,2 ,3 ]
机构：
[1] Univ Melbourne, Dept Resp & Sleep Med Austin Hlth, Melbourne, Vic, Australia
[2] Univ Melbourne, Inst Breathing & Sleep, Fac Med, Melbourne, Vic, Australia
[3] Monash Univ, Cent Clin Sch, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
来源：
CHEST | 2021年 / 160卷 / 05期
关键词：
PIRFENIDONE;
D O I：
10.1016/j.chest.2021.07.033
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1589 / 1591
页数：3
相关论文
共 50 条
  • [1] Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
    Qiu, Ying
    Zhu, Julia
    Elpers, Brandon
    Jiang, Jenny
    Ogbomo, Adesuwa
    Mallampati, Rajesh
    Byrne, Clare
    Tang, Jackson
    Fischer, Aryeh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Antifibrotic therapy for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Teoh, A.
    Glenn, L.
    Corte, T.
    Holland, A.
    RESPIROLOGY, 2023, 28 : 202 - 202
  • [3] Antithrombotics in idiopathic pulmonary fibrosis patients with concomitant antifibrotic therapy: a single centre real world experience
    Stanziola, Anna Agnese
    Pentangelo, Danilo
    D'Angelo, Rossella
    Capitelli, Ludovica
    Rega, Roberto
    Bocchino, Marialuisa
    Malapelle, Umberto
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Effects of Antifibrotic Therapy in the Real-world Progressive Pulmonary Fibrosis
    Niitsu, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Real Life Experience in an Italian Center
    Rosi, E.
    Piccioli, C.
    Inglese, F.
    Gori, L.
    Scola, M.
    Ferrari, K.
    Bartolucci, M.
    Lavorini, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] Efficacy of switching antifibrotic therapy in idiopathic pulmonary fibrosis: real life data
    Raats-ten Cate, Ivonne M.
    Van Moorsel, Coline H. M.
    Van der Meer, Akke-Nynke
    Zanen, Pieter
    Grutters, Jan C.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study
    Zhao, Ruiming
    Xie, Bingbing
    Wang, Xin
    Zhang, Xinran
    Ren, Yanhong
    Wang, Chen
    Dai, Huaping
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2024, 84
  • [8] Antifibrotic Persistence in Idiopathic Pulmonary Fibrosis: A Real-World Experience of 447 Patients
    Thillai, M.
    Harris, E.
    Harding, K.
    Babu, A.
    Verghese, P.
    Fiddler, C.
    Simler, N.
    Parfrey, H.
    Shah, R.
    McLellan, T.
    Atkins, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
    Toby M. Maher
    Mary E. Strek
    Respiratory Research, 20
  • [10] Pattern of Utilization for Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis
    Sedarati, K.
    Gordon, J. A.
    Graham, W. B.
    Sridhar, S.
    Rawal, N.
    Mohajer, K.
    Knowles, N.
    Wei, K.
    Patino, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345